Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

A prevalent and culturable microbiota links ecological balance to clinical stability of the human lung after transplantation.

Tytuł:
A prevalent and culturable microbiota links ecological balance to clinical stability of the human lung after transplantation.
Autorzy:
Das S; Department of Fundamental Microbiology, Biophore, University of Lausanne, Lausanne, Switzerland.
Bernasconi E; Department of Respiratory Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. .
Koutsokera A; Department of Respiratory Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Wurlod DA; Department of Respiratory Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Tripathi V; Department of Fundamental Microbiology, Biophore, University of Lausanne, Lausanne, Switzerland.; Biozentrum, University of Basel, Basel, Switzerland.
Bonilla-Rosso G; Department of Fundamental Microbiology, Biophore, University of Lausanne, Lausanne, Switzerland.
Aubert JD; Department of Respiratory Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Derkenne MF; Department of Respiratory Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Mercier L; Department of Respiratory Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Pattaroni C; Department of Respiratory Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Rapin A; Department of Respiratory Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
von Garnier C; Department of Respiratory Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Marsland BJ; Department of Respiratory Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Engel P; Department of Fundamental Microbiology, Biophore, University of Lausanne, Lausanne, Switzerland. .
Nicod LP; Department of Respiratory Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Źródło:
Nature communications [Nat Commun] 2021 Apr 09; Vol. 12 (1), pp. 2126. Date of Electronic Publication: 2021 Apr 09.
Typ publikacji:
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: [London] : Nature Pub. Group
MeSH Terms:
Graft Rejection/*microbiology
Lung/*microbiology
Lung Transplantation/*adverse effects
Microbiota/*immunology
Pneumonia, Bacterial/*microbiology
Adult ; Allografts/immunology ; Allografts/microbiology ; Bacteria/genetics ; Bacteria/immunology ; Bacteria/isolation & purification ; Bacteria/pathogenicity ; Bacterial Load/immunology ; Bacteriological Techniques ; Bronchoalveolar Lavage Fluid/microbiology ; Bronchoscopy ; DNA, Bacterial/isolation & purification ; Female ; Graft Rejection/diagnosis ; Graft Rejection/immunology ; Humans ; Immune Tolerance ; Longitudinal Studies ; Lung/immunology ; Male ; Metagenomics ; Microbiota/genetics ; Middle Aged ; Pneumonia, Bacterial/diagnosis ; Pneumonia, Bacterial/immunology ; Prospective Studies ; RNA, Ribosomal, 16S/genetics
References:
PLoS One. 2011 Feb 22;6(2):e16384. (PMID: 21364979)
Cell Host Microbe. 2015 Sep 9;18(3):307-19. (PMID: 26299432)
Am J Transplant. 2017 May;17(5):1313-1324. (PMID: 27731934)
Eur Respir J. 2006 Feb;27(2):300-6. (PMID: 16452584)
PLoS Genet. 2014 Sep 11;10(9):e1004596. (PMID: 25210772)
Am J Respir Crit Care Med. 2013 Mar 15;187(6):640-7. (PMID: 23328523)
Front Med (Lausanne). 2017 Jul 17;4:109. (PMID: 28770204)
J Allergy Clin Immunol. 2018 Sep;142(3):815-823.e6. (PMID: 29310905)
mBio. 2015 Mar 03;6(2):e00037. (PMID: 25736890)
Proc Natl Acad Sci U S A. 2016 May 31;113(22):E3101-10. (PMID: 27185949)
Cell Host Microbe. 2008 Oct 16;4(4):337-49. (PMID: 18854238)
J Proteome Res. 2014 Feb 7;13(2):640-9. (PMID: 24289193)
J Immunol. 2009 Apr 1;182(7):4423-31. (PMID: 19299743)
Am J Respir Crit Care Med. 2016 Nov 15;194(10):1252-1263. (PMID: 27248293)
Am J Transplant. 2020 Oct;20(10):2644-2651. (PMID: 32185874)
J Infect Dis. 2018 Nov 5;218(12):1922-1928. (PMID: 30053048)
PLoS One. 2013 Apr 22;8(4):e61217. (PMID: 23630581)
Front Immunol. 2013 May 31;4:129. (PMID: 23755052)
Immunity. 2017 Apr 18;46(4):549-561. (PMID: 28423336)
Cell. 2013 Nov 21;155(5):1178-87. (PMID: 24267896)
Immunol Rev. 2014 Mar;258(1):80-101. (PMID: 24517427)
J Heart Lung Transplant. 2017 Mar;36(3):366-368. (PMID: 27876413)
Sci Transl Med. 2016 Mar 9;8(329):329ra31. (PMID: 26962155)
Pediatr Transplant. 2018 Feb;22(1):. (PMID: 29082660)
Nat Microbiol. 2017 Aug 24;2:17121. (PMID: 28836573)
J Thorac Dis. 2018 Jun;10(6):3849-3868. (PMID: 30069386)
Clin Chest Med. 2011 Jun;32(2):295-310. (PMID: 21511091)
mBio. 2015 Jan 20;6(1):. (PMID: 25604788)
Nat Rev Immunol. 2009 Jul;9(7):465-79. (PMID: 19521399)
J Cyst Fibros. 2007 Apr;6(2):101-9. (PMID: 16844431)
mBio. 2017 Feb 14;8(1):. (PMID: 28196961)
Front Microbiol. 2016 Nov 07;7:1749. (PMID: 27872615)
ISME J. 2020 Mar;14(3):801-814. (PMID: 31836840)
Nature. 2013 Aug 8;500(7461):232-6. (PMID: 23842501)
Sci Rep. 2017 Jan 17;7:40309. (PMID: 28094327)
Respir Res. 2004 Feb 12;5:1. (PMID: 15040820)
Nat Rev Immunol. 2014 Dec;14(12):827-35. (PMID: 25421702)
J Clin Pathol. 1955 Feb;8(1):58-60. (PMID: 14354032)
J Immunol. 2017 Nov 1;199(9):3270-3279. (PMID: 28954888)
Nat Microbiol. 2016 Apr 04;1:16031. (PMID: 27572644)
PLoS Pathog. 2015 Jul 09;11(7):e1004923. (PMID: 26158874)
Sci Rep. 2020 Mar 25;10(1):5446. (PMID: 32214207)
J Exp Med. 1999 Jun 7;189(11):1777-82. (PMID: 10359581)
Am J Transplant. 2020 Mar;20(3):825-833. (PMID: 31665560)
Trends Microbiol. 2016 May;24(5):327-337. (PMID: 26946977)
J Exp Med. 2020 Jan 6;217(1):. (PMID: 31821443)
Am J Transplant. 2015 Jan;15(1):200-9. (PMID: 25403800)
Am J Respir Crit Care Med. 2012 Sep 15;186(6):536-45. (PMID: 22798321)
Am J Respir Crit Care Med. 2011 Oct 15;184(8):957-63. (PMID: 21680950)
Ann Am Thorac Soc. 2015 Jun;12(6):821-30. (PMID: 25803243)
PLoS One. 2018 Jul 6;13(7):e0200428. (PMID: 29979780)
PeerJ. 2016 Oct 18;4:e2584. (PMID: 27781170)
Microbiome. 2013 Jul 01;1(1):19. (PMID: 24450871)
ERJ Open Res. 2018 Jul 03;4(3):. (PMID: 29992131)
Am J Respir Crit Care Med. 2013 Mar 1;187(5):518-26. (PMID: 23328531)
Am J Respir Cell Mol Biol. 2020 Mar;62(3):283-299. (PMID: 31661299)
J Allergy Clin Immunol. 2018 Feb;141(2):718-729.e7. (PMID: 28729000)
J Bacteriol. 1959 Oct;78:520-2. (PMID: 13825774)
Sci Rep. 2016 Jun 08;6:27636. (PMID: 27273266)
PLoS One. 2019 Jan 28;14(1):e0210979. (PMID: 30689633)
Nat Microbiol. 2020 Feb;5(2):379-390. (PMID: 31959969)
Nature. 2017 Nov 23;551(7681):507-511. (PMID: 29143816)
Annu Rev Immunol. 1998;16:27-55. (PMID: 9597123)
Nature. 2011 May 12;473(7346):174-80. (PMID: 21508958)
Am J Physiol Lung Cell Mol Physiol. 2002 Jun;282(6):L1296-304. (PMID: 12003786)
PLoS One. 2010 Jan 05;5(1):e8578. (PMID: 20052417)
Ann Am Thorac Soc. 2019 Nov;16(11):1383-1391. (PMID: 31415219)
Cell Host Microbe. 2018 Dec 12;24(6):857-865.e4. (PMID: 30503510)
Nat Methods. 2010 May;7(5):335-6. (PMID: 20383131)
FEMS Microbiol Lett. 2013 Feb;339(1):57-65. (PMID: 23173619)
Substance Nomenclature:
0 (DNA, Bacterial)
0 (RNA, Ribosomal, 16S)
Entry Date(s):
Date Created: 20210410 Date Completed: 20210503 Latest Revision: 20210503
Update Code:
20240105
PubMed Central ID:
PMC8035266
DOI:
10.1038/s41467-021-22344-4
PMID:
33837203
Czasopismo naukowe
There is accumulating evidence that the lower airway microbiota impacts lung health. However, the link between microbial community composition and lung homeostasis remains elusive. We combine amplicon sequencing and bacterial culturing to characterize the viable bacterial community in 234 longitudinal bronchoalveolar lavage samples from 64 lung transplant recipients and establish links to viral loads, host gene expression, lung function, and transplant health. We find that the lung microbiota post-transplant can be categorized into four distinct compositional states, 'pneumotypes'. The predominant 'balanced' pneumotype is characterized by a diverse bacterial community with moderate viral loads, and host gene expression profiles suggesting immune tolerance. The other three pneumotypes are characterized by being either microbiota-depleted, or dominated by potential pathogens, and are linked to increased immune activity, lower respiratory function, and increased risks of infection and rejection. Collectively, our findings establish a link between the lung microbial ecosystem, human lung function, and clinical stability post-transplant.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies